A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease

Mise à jour : Il y a 4 ans
Référence : NCT02665234

Femme et Homme

Extrait

The purpose of this study is to assess the safety and efficacy of Tavilermide Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye disease.


Critère d'inclusion

  • Keratoconjunctivitis Sicca

Liens